Acendis Pharma raises USD 60 million
Danish biotech company Ascendis Pharma has raised USD 60 million in a new financing round. A good share of that money comes from brand new investors.
BY BENJAMIN WERNER CHRISTENSEN
Danish-based biotech company Ascendis Pharma has raised fresh funding and brought new people into its boardroom, the company writes in a press release, revealing that it has bagged USD 60 million.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Danish company hires yet another American exec
For abonnenter
Biotech Chairman: You pay for the network
For abonnenter
